Immune Checkpoint Inhibitors and the Heart.

Autor: Mocan-Hognogi DL; Internal Medicine Department, 'Iuliu Haţieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania.; 1st Cardiology Department, Emergency Clinical County Hospital, Cluj-Napoca, Romania., Trancǎ S; Surgery Department, 'Iuliu Haţieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Intensive Care Department, Emergency Clinical County Hospital, Cluj-Napoca, Romania., Farcaş AD; Internal Medicine Department, 'Iuliu Haţieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania.; 1st Cardiology Department, Emergency Clinical County Hospital, Cluj-Napoca, Romania., Mocan-Hognogi RF; Mother and Child Department, 'Iuliu Haţieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania.; 2nd Gynecology Department, Emergency Clinical County Hospital, Cluj-Napoca, Romania., Pârvu AV; Oncology Department, 'Iuliu Haţieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Hematological Department, 'Prof. Dr. Ioan Chiricuţǎ' Oncology Institute, Cluj-Napoca, Romania., Bojan AS; Oncology Department, 'Iuliu Haţieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Hematological Department, 'Prof. Dr. Ioan Chiricuţǎ' Oncology Institute, Cluj-Napoca, Romania.

Publikováno v: Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2021 Sep 29; Vol. 8, pp. 726426. Date of Electronic Publication: 2021 Sep 29 (Print Publication: 2021).